![Jacqueline Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jacqueline Li
Public Communications Contact chez ATHENEXPAR
Profil
Jacqueline Li is currently working as the Director-Development at Athenex, Inc. and also holds the position of Chief Financial Officer at Axis Therapeutics Ltd.
She completed her undergraduate degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Jacqueline Li
Sociétés | Poste | Début |
---|---|---|
ATHENEXPAR | Public Communications Contact | 01/01/2017 |
Axis Therapeutics Ltd. | Directeur Financier/CFO | - |
Formation de Jacqueline Li
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Athenex, Inc.
![]() Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Axis Therapeutics Ltd. |